{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:25:33Z","timestamp":1792304733321,"version":"4.4.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response. The minimum dose required for follicular response for a particular patient is yet to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The aim of the study was to compare various clinical and ultrasonographic characteristics of patients with successful OI with different doses of letrozole and individualise the dose of letrozole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting and Design:<\/jats:title>\n                    <jats:p>This prospective cohort study was conducted in a tertiary care teaching hospital from December 2019 to March 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Ninety-seven patients were treated with a starting dose of 2.5 mg of letrozole. The dose was increased to 5 and 7.5 mg without a follicular response. Various clinical and ultrasonographic characteristics were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      Data entered in Microsoft Excel and analysed using SPSS version 27.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 97 patients, 10 were lost to follow-up. Eighty-one (93.1%) patients had a positive response to letrozole. Six (6.9%) patients did not respond to the maximum dose of 7.5 mg of letrozole. Waist circumference, maximum antral follicle count per ovary and volume of the largest ovary were significantly different for patients who responded to different doses of letrozole (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Further analysis revealed that an ovarian volume of 10 cc or more is a risk factor for non-response to 2.5 mg of letrozole.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The ovarian volume can be considered when determining the dose of letrozole in PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_72_25","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T03:00:09Z","timestamp":1750388409000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study"],"prefix":"10.4103","volume":"18","author":[{"given":"Pratyasha","family":"Peepal","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynaecology, IMS and SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmalaya","family":"Thakur","sequence":"additional","affiliation":[{"name":"Center for Human Reproduction, IMS and SUM Hospital, Siksha 'O' Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhuti","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Human Reproduction, IMS and SUM Hospital, Siksha 'O' Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotiranjan","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, IMS and SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Pradhan","sequence":"additional","affiliation":[{"name":"Center for Human Reproduction, IMS and SUM Hospital, Siksha 'O' Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynaecology, IMS and SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"e000548","DOI":"10.1136\/bmjmed-2023-000548","article-title":"Polycystic ovary syndrome: Pathophysiology and therapeutic opportunities","volume":"2","author":"Dong","year":"2023","journal-title":"BMJ Med"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bmj.327.7414.546","article-title":"Anovulation","volume":"327","author":"Hamilton-Fairley","year":"2003","journal-title":"BMJ"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.39335.462303.80","article-title":"Managing anovulatory infertility and polycystic ovary syndrome","volume":"335","author":"Balen","year":"2007","journal-title":"BMJ"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.fertnstert.2015.07.332","article-title":"What is the ideal starting dose for patients utilizing Letrozole for ovulation induction? Analysis of 4251 cycles","volume":"104","author":"Rodriguez-Purata","year":"2015","journal-title":"Fertil Steril"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/jhrs.jhrs_133_24","article-title":"Evaluation of predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome: A prospective cohort study","volume":"17","author":"Tholiya","year":"2024","journal-title":"J Hum Reprod Sci"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/humrep\/dex227","article-title":"Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome","volume":"32","author":"Amer","year":"2017","journal-title":"Hum Reprod"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijgo.2003.11.010","article-title":"Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome","volume":"85","author":"Al-Omari","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"R14-20260422","first-page":"879","article-title":"Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome","volume":"6","author":"Nazik","year":"2012","journal-title":"Health Med"},{"key":"R15-20260422","first-page":"268","article-title":"Comparing the effect of clomiphene citrate and letrozole on ovulation induction in infertile women with polycystic ovary syndrome","volume":"70","author":"Najafi","year":"2020","journal-title":"J Pak Med Assoc"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/09513590.2017.1332174","article-title":"Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: A prospective randomized trial","volume":"33","author":"Liu","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5530\/ami.2016.2.19","article-title":"The effect of clomiphene citrate versus tamoxifen versus letrozol on endometrial thickness and blood flow in ovulation induction in women with polycystic ovaries","volume":"3","author":"Asem","year":"2016","journal-title":"Acta Med Int"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"e12630","DOI":"10.1002\/rmb2.12630","article-title":"Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity","volume":"24","author":"Baba","year":"2025","journal-title":"Reprod Med Biol"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.rbmo.2020.12.006","article-title":"Influence of ethnicity on different aspects of polycystic ovary syndrome: A systematic review","volume":"42","author":"Sendur","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.fertnstert.2005.08.016","article-title":"Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone\/follicle-stimulating hormone ratio","volume":"85","author":"Elnashar","year":"2006","journal-title":"Fertil Steril"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12902-023-01336-z","article-title":"Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/uog.7505","article-title":"Quantitative analysis of antral follicle number and size: A comparison of two-dimensional and automated three-dimensional ultrasound techniques","volume":"35","author":"Deb","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7863\/jum.2012.31.7.1015","article-title":"Two- and three-dimensional sonographic and color Doppler techniques for diagnosis of polycystic ovary syndrome. The stromal\/ovarian volume ratio as a new diagnostic criterion","volume":"31","author":"Battaglia","year":"2012","journal-title":"J Ultrasound Med"},{"key":"R24-20260422","first-page":"2291","article-title":"Comparison of the effect of clomiphene citrate and letrozole on the endometrial parameters of PCOS women","volume":"9","author":"Hussein","year":"2017","journal-title":"J Pharm Sci Res"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.fertnstert.2018.11.030","article-title":"A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome","volume":"111","author":"Mejia","year":"2019","journal-title":"Fertil Steril"},{"key":"R26-20260422","first-page":"17","article-title":"A randomized clinical trial on comparing the cycle characteristics of two different initiation days of letrozole treatment in clomiphene citrate resistant PCOS patients in IUI cycles","volume":"9","author":"Ghomian","year":"2015","journal-title":"Int J Fertil Steril"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_72_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:42:41Z","timestamp":1787838161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_72_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_72_25","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2025-04-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}